Buy me a coffee
Home › FDA recalls › Atorvastatin Calcium Tablets
CLASS II · ModerateFDA

MSN Laboratories Private Limited (Formulations Division, Unit-II) recalls Atorvastatin Calcium Tablets

📅 Oct 21, 2026 · 📍 Nationwide
Recalling company
MSN Laboratories Private Limited (Formulations Division, Unit-II)
Product
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Reason
Presence of Foreign Tablets/Capsules
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Oct 21, 2026
Reported
Nov 4, 2026
Distribution
Nationwide in the USA.
Status
Ongoing
Quantity
13,296 1,000-count bottles
Lot / codes
Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.
Company location
Rangareddy District
Recall type
Voluntary: Firm initiated
Recall number
D-0113-2027
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0113-2027 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.